+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Female Infertility Diagnosis & Treatment Market - Global Forecast 2026-2032- Product Image
Female Infertility Diagnosis & Treatment Market - Global Forecast 2026-2032- Product Image
New

Female Infertility Diagnosis & Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977741
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Female Infertility Diagnosis & Treatment Market is experiencing rapid transformation, driven by scientific innovation, evolving regulatory conditions, and heightened expectations for accessible, patient-centered solutions. Senior executives must stay ahead of core trends to guide their organizations through investment, operational, and competitive decisions in this dynamic environment.

Market Snapshot: Female Infertility Diagnosis & Treatment Market

The global Female Infertility Diagnosis & Treatment Market is entering a new phase of growth, with market value increasing from USD 5.29 billion in 2025 to USD 5.72 billion in 2026. The sector is projected to reach USD 9.32 billion by 2032, achieving a CAGR of 8.40%. This trajectory reflects broader global shifts: greater reproductive health awareness is encouraging early intervention, while demographic and lifestyle factors are driving demand for precise diagnostics and innovative therapies. Industry progress is further shaped by expanded access to personalized treatment covered through a mix of public, private, and out-of-pocket financing, as well as the adoption of sophisticated technologies in both established and emerging healthcare markets.

Scope & Segmentation: Comprehensive Breakdown of the Female Infertility Diagnosis & Treatment Ecosystem

  • Therapeutic Modalities: Assisted reproductive technologies, which include in vitro fertilization, gamete intrafallopian transfer, intracytoplasmic sperm injection, and intrauterine insemination; cryopreservation of embryos and oocytes to extend fertility potential; conventional and targeted fertility medications; surgical solutions such as hysteroscopic surgery, laparoscopic techniques, myomectomy, and tubal procedures.
  • Diagnostic Techniques: Encompass blood-based hormone assays (such as anti-Mullerian hormone, follicle-stimulating hormone, luteinizing hormone, and prolactin), robust genetic testing protocols, advanced imaging tools including hysterosalpingography and ultrasound, and the use of minimally invasive laparoscopy for comprehensive assessment.
  • Patient Classification: Differentiates between primary infertility (where conception has never occurred) and secondary infertility (difficulty following a prior conception), allowing tailored diagnostic and therapeutic pathways.
  • Distribution Channels: Include clinic-based services, home care testing solutions, hospital provisions, and independent laboratories, giving providers and patients flexible access points and varying complexity of services.
  • End Users: Range from general gynecology clinics to specialized fertility centers and research-affiliated institutions; each employing unique service delivery models and contributing to different aspects of patient care and research advancement.
  • Regional Coverage: Americas, Europe, Middle East & Africa, and Asia-Pacific are the main geographic segments, each presenting distinct adoption rates, reimbursement schemes, and regulatory environments influencing technology roll-out and patient access.
  • Technology Focus: The sector benefits from artificial intelligence, genomics applications, telehealth platforms, and digital health tools, which are shaping diagnostic precision and patient engagement across both developed and emerging healthcare systems.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Growth in precision medicine and digital health is empowering clinicians to develop personalized infertility management strategies and increase patient involvement.
  • AI-enhanced workflows, such as automated embryo selection and improved cryopreservation, are optimizing laboratory efficiencies and supporting broader fertility preservation choices.
  • The competitive landscape includes both global multinationals and innovative entrants focusing on telehealth, remote monitoring, and less invasive diagnostics, diversifying patient engagement models.
  • Collaborative efforts between academia, clinical practices, and biotechnology companies are accelerating the adoption of novel research findings into practical clinical protocols.
  • Regional disparities in healthcare investment, insurance coverage, and regulatory progress directly affect the pace of technology implementation and the reach of fertility services.
  • Comprehensive use of diagnostic data enables clinicians to more accurately identify infertility causes, leading to better customized intervention plans and improved patient outcomes.

Tariff Impact: Market Adjustments and Strategic Sourcing Post-2025

Recent tariff policy changes in the United States are impacting cost structures and supply chain strategies in the Female Infertility Diagnosis & Treatment Market. Elevated duties on essential reagents and laboratory equipment prompt clinics and providers to explore domestic suppliers and diversify procurement channels. These responses are reinforcing the importance of robust sourcing strategies, supply chain resilience, and agile pricing models to mitigate disruptions and sustain affordability for both providers and patients.

Methodology & Data Sources

This market analysis is anchored on primary interviews with clinical experts and industry suppliers, delivering up-to-date, practice-focused insights. Secondary research draws on peer-reviewed journals, industry analyses, and clinical studies to ensure comprehensive data triangulation. Rigor is enhanced through blind peer reviews and editorial validation of findings.

Why This Report Matters

  • Provides sector-specific intelligence supporting C-suite investment and operational strategy within the Female Infertility Diagnosis & Treatment Market.
  • Delivers a granular, segmented perspective on competitive positioning, technology adoption, and service model evolution, allowing for targeted planning and benchmarking.
  • Prepares stakeholders to anticipate and adapt to regulatory changes, payer requirements, and shifting patient needs, promoting resilient and informed decision-making.

Conclusion

This report equips industry leaders with actionable insight into technology, regulation, and evolving care models, supporting strategic growth and enhanced patient outcomes in the Female Infertility Diagnosis & Treatment Market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Female Infertility Diagnosis & Treatment Market, by Treatment Method
8.1. Assisted Reproductive Technology
8.1.1. Gamete Intrafallopian Transfer
8.1.2. In Vitro Fertilization
8.1.3. Intracytoplasmic Sperm Injection
8.1.4. Intrauterine Insemination
8.2. Cryopreservation
8.2.1. Embryo Cryopreservation
8.2.2. Oocyte Cryopreservation
8.2.3. Sperm Cryopreservation
8.3. Fertility Medications
8.3.1. Clomiphene Citrate
8.3.2. Gonadotropins
8.3.3. Letrozole
8.4. Surgical Intervention
8.4.1. Hysteroscopic Surgery
8.4.2. Laparoscopic Surgery
8.4.3. Myomectomy
8.4.4. Tubal Surgery
9. Female Infertility Diagnosis & Treatment Market, by Diagnosis Technique
9.1. Blood Diagnostics
9.1.1. Anti Mullerian Hormone Test
9.1.2. Follicle Stimulating Hormone Test
9.1.3. Luteinizing Hormone Test
9.1.4. Prolactin Test
9.2. Genetic Testing
9.3. Hysterosalpingography
9.4. Laparoscopy
9.5. Ultrasound Imaging
10. Female Infertility Diagnosis & Treatment Market, by Type of Infertility
10.1. Primary Infertility
10.2. Secondary Infertility
11. Female Infertility Diagnosis & Treatment Market, by Distribution Channel
11.1. Clinic Services
11.1.1. General Gynecology Clinics
11.1.2. Specialized Fertility Clinics
11.2. Home Care Testing
11.3. Hospital Services
11.4. Independent Laboratories
12. Female Infertility Diagnosis & Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Female Infertility Diagnosis & Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Female Infertility Diagnosis & Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Female Infertility Diagnosis & Treatment Market
16. China Female Infertility Diagnosis & Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Diagnostics
17.6. Bayer AG
17.7. Cook Group Incorporated
17.8. CooperSurgical Inc.
17.9. F. Hoffmann-La Roche Ltd.
17.10. Ferring B.V.
17.11. FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
17.12. Genea Pty Limited
17.13. GlaxoSmithKline PLC
17.14. Halotech DNA S.L.
17.15. Merck & Co., Inc.
17.16. Qiagen N.V.
17.17. Theramex by Kanga Health Ltd.
17.18. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY IN VITRO FERTILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPERM CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPERM CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLOMIPHENE CITRATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GONADOTROPINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GONADOTROPINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GONADOTROPINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LETROZOLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LETROZOLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LETROZOLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MYOMECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY MYOMECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TUBAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ANTI MULLERIAN HORMONE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ANTI MULLERIAN HORMONE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ANTI MULLERIAN HORMONE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FOLLICLE STIMULATING HORMONE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FOLLICLE STIMULATING HORMONE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FOLLICLE STIMULATING HORMONE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LUTEINIZING HORMONE TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LUTEINIZING HORMONE TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LUTEINIZING HORMONE TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PROLACTIN TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PROLACTIN TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PROLACTIN TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HYSTEROSALPINGOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ULTRASOUND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY INFERTILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY INFERTILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY INFERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY INFERTILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY INFERTILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY INFERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENERAL GYNECOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENERAL GYNECOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GENERAL GYNECOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SPECIALIZED FERTILITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOME CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY HOSPITAL SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 162. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 164. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 171. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. EUROPE FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 184. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 186. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 188. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 189. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 190. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 192. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 193. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. AFRICA FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 207. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 209. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 211. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 212. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 213. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 214. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 215. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 216. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. ASEAN FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 218. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 220. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 222. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 223. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 224. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 225. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 226. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 227. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. GCC FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 240. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 242. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 243. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 244. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 245. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 246. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 247. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 248. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 249. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. BRICS FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CLINIC SERVICES, 2018-2032 (USD MILLION)
TABLE 251. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT METHOD, 2018-2032 (USD MILLION)
TABLE 253. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
TABLE 255. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY FERTILITY MEDICATIONS, 2018-2032 (USD MILLION)
TABLE 256. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 257. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS TECHNIQUE, 2018-2032 (USD MILLION)
TABLE 258. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY BLOOD DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 259. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE OF INFERTILITY, 2018-2032 (USD MILLION)
TABLE 260. G7 FEMALE INFERTILITY DIAGNOSIS & TREATMENT M

Companies Mentioned

The key companies profiled in this Female Infertility Diagnosis & Treatment market report include:
  • Abbott Diagnostics
  • Bayer AG
  • Cook Group Incorporated
  • CooperSurgical Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ferring B.V.
  • FUJIFILM Irvine Scientific, Inc. by FUJIFILM Holdings Corporation
  • Genea Pty Limited
  • GlaxoSmithKline PLC
  • Halotech DNA S.L.
  • Merck & Co., Inc.
  • Qiagen N.V.
  • Theramex by Kanga Health Ltd.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 5.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.32 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Female Infertility Market Report 2025 - Product Image

Female Infertility Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Female Infertility - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Female Infertility - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Female Infertility Diagnosis - Global Strategic Business Report - Product Image

Female Infertility Diagnosis - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Female Infertility - Pipeline Insight, 2025 - Product Image

Female Infertility - Pipeline Insight, 2025

  • Drug Pipelines
  • 75 Pages
  • Global
From
Infertility Treatment Market - Global Forecast 2025-2032 - Product Image

Infertility Treatment Market - Global Forecast 2025-2032

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.